Audit in process? Call the number on your audit letter to get options.
Site Logo
Health care professionals website
DPL Global Search
DPL Utility Nav
DPL Main Nav
DPL Global Search
DPL Utility Nav
Breadcrumbs
SubHero Banner
RxNews®
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Furoscix® (furosemide) – Expanded indication
August 12, 2024 - scPharmaceuticals announced the FDA approval of Furoscix (furosemide), for the treatment of congestion due to fluid overload in adult patients with chronic heart failure.